跳至主要内容
临床试验/IRCT201205279373N1
IRCT201205279373N1已完成未知

The effects of glutamine supplementation on lipid profile, inflammatory and metabolic factors in type 2 diabetes.

Endocrinology & Metabolism Research Institute, Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • Patient diagnosed with type 2 diabetes based on ADA definition or who only take oral antidiabetic drug
  • Exclusion criteria: history of drug dependence; body mass index (BMI) =35 kg/m2; history of cancer; treatment with anti-inflammatory; corticosteroid; hormonal or antibiotic agents; a restrictive diet or weight change = 5 kg during the 3months prior to study; systolic blood pressure >160 mmHg and/or diastolic blood pressure > 90 mmHg; fatty liver disease; liver or kidney disease; autoimmune disease; pregnancy and lactation; any change in treatment with oral hypoglycemic; anti hypertensive and antilipid agents during the study; use of weight loss medications; HbA1C >8

排除标准

  • 未提供

研究者

发起方
Endocrinology & Metabolism Research Institute, Tehran University of Medical Sciences

相似试验